Cell-surface receptors on tumor cells

The term “cell-surface receptors on tumor cells” refers to a broad class of transmembrane proteins present on the exterior membrane of cancer cells. These receptors include G protein–coupled receptors (GPCRs), ion channel receptors, and enzyme-linked receptors, all of which mediate critical extracellular signals into the cell, affecting processes such as proliferation, apoptosis, immune recognition, and metastasis[1][3][7]. The abnormal quantity, structure, or function of these receptors in tumor cells compared to normal tissue underlies their value as therapeutic targets for precision oncology, including monoclonal antibody therapy, CAR-T cell therapy, immunotoxins, and other modular therapies[2][5][6]. The specific identity of the receptor(s) in question is not defined in this entry, which is a generic grouping rather than a specific molecular target, and may refer to hundreds of distinct proteins that vary across cancer types. Notes on correctness: This “target” as stated is a catch-all, not a single molecular entity. It does not correspond to a unique, standardized molecular target (unlike “HER2 receptor” or “Epidermal growth factor receptor”). For structured data purposes, this entry is too broad and should be replaced by more specific canonical forms referring to individual well-defined receptors[5][2][1].

Other names

Cell membrane receptors on tumor cellsTumor cell-surface receptorsMembrane receptors on cancer cells

Ligand binding and downstream signal transduction; Activation or inhibition of cell growth; Induction of immune-mediated cell death; Delivery of cytotoxins to tumor cells